Company / Gross Margin
Yubo International Biotech Ltd Gross Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
66.1%
FY2025
5-year range
50.5% / 76.3%
FY2022-FY2025
Trend
-13.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from 69.3% to 66.1% over the past 2 years.
Based on SEC 10-K filings.
66.1% in FY2025 with a 3-year CAGR of +15.6%.
Declined from 69.3% to 66.1% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- +15.6pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, gross margin decreased 13.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -14.17 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 66.1% | -13.4% |
| FY2024 | 76.3% | +10.1% |
| FY2023 | 69.3% | +37.3% |
| FY2022 | 50.5% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |